Concomitant pancreatic neuroendocrine tumors in hereditary tumor syndromes: who, when and how to operate?
Abstract. Pancreatic neuroendocrine tumors (pNETs) might present as part of a complex of hereditary (familial) syndromes caused by germline mutations such as multiple endocrine neoplasia type 1 (MEN1), von Hippel–Lindau syndrome (VHL), tuberous sclerosis, and neurofibromatosis syndromes. Hereditary...
Main Authors: | Xu Han, PhD, MD, Wenhui Lou, PhD, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2019-06-01
|
Series: | Journal of Pancreatology |
Online Access: | http://journals.lww.com/10.1097/JP9.0000000000000016 |
Similar Items
-
Pancreatic Neuroendocrine Tumors Presenting with Hypercalcitonemia
by: Alexandra Chrisoulidou, MD, PhD, et al.
Published: (2015-01-01) -
Perspective of neo-adjuvant/conversion and adjuvant therapy for pancreatic neuroendocrine tumors
by: Luohai Chen, MD, PhD, et al.
Published: (2019-09-01) -
Histological grades and prognostic markers of well-differentiated pancreatic neuroendocrine tumor (WDPNET)
by: Yongchao Li, MD, PhD, et al.
Published: (2020-12-01) -
Elevated Intact Parathyroid Hormone Produced by a Cervical Neuroendocrine Tumor
by: Suset Dueñas Disotuar, MD, et al.
Published: (2018-07-01) -
Hypovascular pancreatic neuroendocrine tumor with hepatic metastases: A case report and literature review
by: Ngo-Van Doan, MD, et al.
Published: (2021-06-01)